azomycin has been researched along with oxadiazoles in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Hori, H; Inayana, S; Ono, K; Shibamoto, Y; Shibata, T; Takahashi, M | 1 |
Keshavarz, MH; Shokrolahi, A; Zali, A | 1 |
Gong, HB; Hu, Y; Li, Y; Liu, ZJ; Luo, Y; Zhang, S; Zhu, DD; Zhu, HL | 1 |
Athar, F; Azam, A; Bhat, AR; Wani, MY | 1 |
Aiub, CA; Araújo, JS; Batista, Dda G; Batista, MM; Britto, C; da Silva, CF; da Silva, PB; de Souza, EM; Hargrove, TY; Kim, K; Lepesheva, GI; Lionel, J; Pavão, BP; Soeiro, Mde N; Sulikowski, G; Waterman, MR | 1 |
Berndorff, D; Chang, E; Cheng, Z; Ellinghaus, P; Gambhir, SS; Gekeler, V; Liu, H; Liu, S; Unterschemmann, K | 1 |
Batista, DG; Britto, C; da Silva, CF; de Araújo, JS; Ferreira, CG; Guedes-da-Silva, FH; Lepesheva, GI; Meuser, MB; Moreira, OC; Simões-Silva, MR; Soeiro, Mde N | 1 |
7 other study(ies) available for azomycin and oxadiazoles
Article | Year |
---|---|
[Radioprotective phenomena in murine tumors induced by radiosensitizers at high dose levels].
Topics: Animals; Combined Modality Therapy; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxadiazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1986 |
A simple approach for predicting impact sensitivity of polynitroheteroarenes.
Topics: Explosions; Explosive Agents; Heterocyclic Compounds, 1-Ring; Materials Testing; Models, Theoretical; Neural Networks, Computer; Nitro Compounds; Nitrofurans; Nitroimidazoles; Oxadiazoles; Pyrazoles; Pyridines; Pyrimidines; Structure-Activity Relationship; Triazoles | 2009 |
Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Anti-Infective Agents; Binding Sites; Computer Simulation; Drug Design; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nitroimidazoles; Oxadiazoles; Protein Structure, Tertiary; Structure-Activity Relationship | 2012 |
Nitroimidazolyl hydrazones are better amoebicides than their cyclized 1,3,4-oxadiazoline analogues: In vitro studies and Lipophilic efficiency analysis.
Topics: Amebicides; Antiparasitic Agents; Cell Survival; Dose-Response Relationship, Drug; Entamoeba histolytica; Hep G2 Cells; Humans; Hydrazones; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Nitroimidazoles; Oxadiazoles; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2013 |
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Drug Resistance; Endoplasmic Reticulum; Golgi Apparatus; Imidazoles; Male; Mice; Microscopy, Electron, Transmission; Nitroimidazoles; Oxadiazoles; Protozoan Proteins; Sterol 14-Demethylase; Thiazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nitroimidazoles; Oxadiazoles; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazoles; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection.
Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Gene Expression; Imidazoles; Immunosuppressive Agents; Male; Mice; Nitroimidazoles; Oxadiazoles; Parasitemia; Sex Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2015 |